Insider filing · NTLA
John M Leonard
President and CEO
profile →
Intellia Therapeutics, Inc.
NTLA · Healthcare · 10 filings in 24 months
ticker →
John M Leonard sold $251K of Intellia Therapeutics (NTLA)
Executed Aug 20, disclosed Aug 24, 4 days later.
Value, as filed
$251K
19,890 sh × $12.60
Executed
Aug 20
the trade date, as filed
Disclosed
Aug 24
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JLJohn M Leonard (President and CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Intellia Therapeutics, Inc. (NTLA). The largest single filing was $785K of NTLA (82,791 sh across 2 lots, as filed), executed Dec 11 2025.
The name
NTLAHealthcare · Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics usi…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John M Leonard in NTLA
NTLASALE
Intellia Therapeutics, Inc.
$314K34,146 sh × $9.21
Exec Jan 5
Filed Jan 7 · 5:30 PM ET NTLASALE Intellia Therapeutics, Inc. $785K
82,791 sh across 2 lots
Exec Dec 11 2025
Filed Dec 12 2025 · 5:30 PM ET NTLASALE Intellia Therapeutics, Inc. $327K
26,807 sh × $12.18
Exec Jan 3 2025
Filed Jan 7 2025 · 5:30 PM ET